This small but growing Danish biochemical company must choose between several financing options, including convertible Eurobonds, the right to place in Denmark and the issue of new ordinary shares in the United States. The case includes a wide range of issues concerning the ability of multinational companies to reduce the cost of capital, referring to the various capital markets around the world. "Hide
on W. Carl Kester Source: Harvard Business School 12 pages. Publication Date: February 18, 1986. Prod. #: 286084-PDF-ENG
Related Case Solutions & Analyses:
Implementation of Balanced Scorecard
Dell Corporation
Transportation of Pratt & Whitney north heaven (Abridged
On the Ropes: Knock Out! Panties
Barbara Lynch Gruppo: An Entrepreneurial Journey
From Blues Brother to Industry Leader: Growing Revenues at ParkNPool
Lab Mice and Bank Loans: General National Bank and Salazar Services
1366 Technologies: Scaling the Venture (Abridged)
The Buenos Aires-Colonia Bridge (B): Sequel
Coming to Grips with Deregulation: Bay State Gas
